Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ABBV

AbbVie

$79.94

-1.29 (-1.59%)

, AGN

Allergan

$149.70

-3.84 (-2.50%)

09:00
03/25/19
03/25
09:00
03/25/19
09:00
Conference/Events
Academy of Managed Care Pharmacy to hold annual meeting »

Managed Care &…

ABBV

AbbVie

$79.94

-1.29 (-1.59%)

AGN

Allergan

$149.70

-3.84 (-2.50%)

AMRN

Amarin

$17.64

-1.13 (-6.02%)

AZN

AstraZeneca

$42.58

-0.37 (-0.86%)

BAYRY

Bayer

$0.00

(0.00%)

BIIB

Biogen

$217.29

-9.42 (-4.16%)

NVO

Novo Nordisk

$50.70

-1.495 (-2.86%)

LLY

Eli Lilly

$128.30

0.08 (0.06%)

PODD

Insulet

$97.74

-4.15 (-4.07%)

INSM

Insmed

$28.21

-0.99 (-3.39%)

GILD

Gilead

$64.07

-0.85 (-1.31%)

TEVA

Teva

$16.35

-0.73 (-4.27%)

TSRO

Tesaro

$0.00

(0.00%)

DNA

Bought by RHHBY

$0.00

(0.00%)

SYNH

Syneos Health

$50.35

-1.78 (-3.41%)

SUPN

Supernus

$35.64

-2.1 (-5.56%)

CVS

CVS Health

$56.05

-1.35 (-2.35%)

SNSS

Sunesis

$1.30

0.34 (35.42%)

AIPT

Precision Therapeutics

$0.82

-0.005 (-0.61%)

CHRS

Coherus Biosciences

$14.32

-1.18 (-7.61%)

CELG

Celgene

$88.34

-1.28 (-1.43%)

WTKWY

Wolters Kluwer

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 12

    Apr

  • 24

    Apr

  • 30

    Apr

  • 30

    Apr

  • 01

    May

  • 18

    May

  • 28

    May

  • 27

    Jun

  • 03

    Sep

  • 04

    Nov

Over a week ago
INSM

Insmed

$28.93

-0.415 (-1.41%)

07:59
03/08/19
03/08
07:59
03/08/19
07:59
Recommendations
Insmed analyst commentary at Canaccord »

Insmed price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
INSM

Insmed

$25.57

-0.42 (-1.62%)

07:33
02/22/19
02/22
07:33
02/22/19
07:33
Hot Stocks
Insmed sees FY19 ARIKAYCE revenues $80M-$90M »

Insmed expects cash-based…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

INSM

Insmed

$26.14

0.13 (0.50%)

08:12
02/15/19
02/15
08:12
02/15/19
08:12
Upgrade
Insmed rating change at JMP Securities »

Insmed upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSM

Insmed

$26.14

0.13 (0.50%)

06:28
02/15/19
02/15
06:28
02/15/19
06:28
Upgrade
Insmed rating change at JMP Securities »

Insmed upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANTM

Anthem

$264.48

2.6 (0.99%)

, CI

Cigna

$195.52

1.05 (0.54%)

11:00
01/18/19
01/18
11:00
01/18/19
11:00
Conference/Events
Morgan Stanley healthcare/pharma analysts hold analyst/industry conference call »

Healthcare Services &…

ANTM

Anthem

$264.48

2.6 (0.99%)

CI

Cigna

$195.52

1.05 (0.54%)

HUM

Humana

$295.55

4.66 (1.60%)

MOH

Molina Healthcare

$137.34

1.92 (1.42%)

UNH

UnitedHealth

$261.78

2.06 (0.79%)

MRK

Merck

$75.73

0.13 (0.17%)

PFE

Pfizer

$42.42

-0.04 (-0.09%)

INSM

Insmed

$24.52

-0.15 (-0.61%)

PTLA

Portola Pharmaceuticals

$26.25

0.63 (2.46%)

GILD

Gilead

$68.99

0.34 (0.50%)

TMO

Thermo Fisher

$239.79

1.62 (0.68%)

QGEN

Qiagen

$36.89

0.25 (0.68%)

ABT

Abbott

$71.62

1.09 (1.55%)

PODD

Insulet

$74.87

0.06 (0.08%)

TFX

Teleflex

$257.01

2.42 (0.95%)

ZBH

Zimmer Biomet

$105.00

-1.16 (-1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 27

    Jan

  • 28

    Jan

  • 29

    Jan

  • 30

    Jan

  • 30

    Jan

  • 30

    Jan

  • 01

    Feb

  • 01

    Feb

  • 06

    Feb

  • 12

    Feb

  • 16

    Feb

  • 19

    Feb

  • 11

    Apr

  • 18

    May

  • 28

    May

MS

Morgan Stanley

$44.48

1.59 (3.71%)

, LPCN

Lipocine

$1.59

(0.00%)

09:06
01/17/19
01/17
09:06
01/17/19
09:06
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Lipocine (LPCN),…

MS

Morgan Stanley

$44.48

1.59 (3.71%)

LPCN

Lipocine

$1.59

(0.00%)

ZFGN

Zafgen

$4.73

-0.06 (-1.25%)

INSM

Insmed

$23.24

-0.11 (-0.47%)

CARS

Cars.com

$23.14

-0.26 (-1.11%)

BBT

BB&T

$47.55

1.2 (2.59%)

KEY

KeyCorp

$16.75

0.44 (2.70%)

FAST

Fastenal

$54.11

-0.47 (-0.86%)

EA

Electronic Arts

$89.90

0.42 (0.47%)

RVNC

Revance

$18.11

-2.11 (-10.44%)

ACB

Aurora Cannabis

$7.33

0.35 (5.01%)

MTB

M&T Bank

$154.45

3.04 (2.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 05

    Feb

  • 11

    Feb

  • 11

    Feb

  • 25

    Feb

  • 23

    May

  • 17

    Jan

INSM

Insmed

$23.24

-0.11 (-0.47%)

06:11
01/17/19
01/17
06:11
01/17/19
06:11
Upgrade
Insmed rating change at Goldman Sachs »

Insmed upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSM

Insmed

$22.05

-0.63 (-2.78%)

08:10
01/15/19
01/15
08:10
01/15/19
08:10
Recommendations
Insmed analyst commentary at Canaccord »

Insmed price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSM

Insmed

$14.87

0.93 (6.67%)

16:11
01/04/19
01/04
16:11
01/04/19
16:11
Hot Stocks
Insmed sees Q4 Arikayce sales of $9,8M »

Insmed provided an update…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.